Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fractional Flow Reserve, Myocardial | 22 | 2022 | 137 | 4.120 |
Why?
|
| Coronary Angiography | 40 | 2022 | 866 | 3.730 |
Why?
|
| Computed Tomography Angiography | 32 | 2022 | 424 | 3.720 |
Why?
|
| Coronary Artery Disease | 28 | 2022 | 696 | 3.270 |
Why?
|
| Coronary Stenosis | 21 | 2022 | 246 | 2.980 |
Why?
|
| Transcatheter Aortic Valve Replacement | 8 | 2022 | 90 | 1.850 |
Why?
|
| Tomography, X-Ray Computed | 22 | 2022 | 2324 | 1.720 |
Why?
|
| Aortic Valve Stenosis | 7 | 2022 | 177 | 1.610 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2022 | 164 | 1.480 |
Why?
|
| Machine Learning | 12 | 2022 | 170 | 1.250 |
Why?
|
| Vascular Calcification | 8 | 2020 | 131 | 1.090 |
Why?
|
| Plaque, Atherosclerotic | 9 | 2022 | 125 | 0.970 |
Why?
|
| Predictive Value of Tests | 20 | 2022 | 1465 | 0.960 |
Why?
|
| Coronary Vessels | 8 | 2021 | 313 | 0.830 |
Why?
|
| Mitral Valve | 2 | 2020 | 166 | 0.780 |
Why?
|
| Heart Valve Diseases | 1 | 2022 | 123 | 0.770 |
Why?
|
| Retrospective Studies | 31 | 2022 | 7268 | 0.700 |
Why?
|
| Percutaneous Coronary Intervention | 5 | 2022 | 137 | 0.650 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 7 | 2020 | 373 | 0.630 |
Why?
|
| Catheter Ablation | 1 | 2020 | 229 | 0.610 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 248 | 0.590 |
Why?
|
| Multidetector Computed Tomography | 4 | 2019 | 60 | 0.590 |
Why?
|
| Heart | 3 | 2020 | 850 | 0.560 |
Why?
|
| Middle Aged | 31 | 2021 | 21119 | 0.450 |
Why?
|
| Acute Coronary Syndrome | 3 | 2021 | 195 | 0.430 |
Why?
|
| Humans | 52 | 2022 | 68549 | 0.430 |
Why?
|
| Female | 40 | 2022 | 38021 | 0.400 |
Why?
|
| Reproducibility of Results | 11 | 2020 | 2077 | 0.380 |
Why?
|
| Male | 37 | 2022 | 37283 | 0.380 |
Why?
|
| ROC Curve | 11 | 2019 | 392 | 0.370 |
Why?
|
| Aged | 21 | 2021 | 14842 | 0.360 |
Why?
|
| Chest Pain | 2 | 2021 | 151 | 0.350 |
Why?
|
| Preoperative Care | 2 | 2021 | 275 | 0.350 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 4843 | 0.330 |
Why?
|
| Aortic Valve | 5 | 2022 | 249 | 0.330 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2019 | 75 | 0.320 |
Why?
|
| Myocardial Perfusion Imaging | 2 | 2021 | 100 | 0.300 |
Why?
|
| Radiation Dosage | 7 | 2017 | 419 | 0.290 |
Why?
|
| Prognosis | 10 | 2022 | 2093 | 0.280 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2020 | 689 | 0.280 |
Why?
|
| Severity of Illness Index | 10 | 2022 | 1851 | 0.270 |
Why?
|
| Risk Assessment | 7 | 2021 | 2004 | 0.260 |
Why?
|
| Decision Making | 2 | 2020 | 410 | 0.260 |
Why?
|
| Calcinosis | 2 | 2017 | 241 | 0.260 |
Why?
|
| Contrast Media | 6 | 2020 | 595 | 0.250 |
Why?
|
| Feasibility Studies | 6 | 2021 | 652 | 0.220 |
Why?
|
| Multimodal Imaging | 1 | 2022 | 62 | 0.200 |
Why?
|
| Cardiac Catheterization | 2 | 2022 | 419 | 0.200 |
Why?
|
| Algorithms | 4 | 2019 | 1195 | 0.180 |
Why?
|
| Standard of Care | 1 | 2020 | 22 | 0.180 |
Why?
|
| Vascular Access Devices | 1 | 2020 | 21 | 0.180 |
Why?
|
| Tin | 2 | 2017 | 16 | 0.180 |
Why?
|
| Pattern Recognition, Automated | 1 | 2020 | 70 | 0.180 |
Why?
|
| Sensitivity and Specificity | 7 | 2018 | 1753 | 0.180 |
Why?
|
| Hemodynamics | 3 | 2019 | 705 | 0.180 |
Why?
|
| Costs and Cost Analysis | 1 | 2020 | 193 | 0.170 |
Why?
|
| Echocardiography | 1 | 2022 | 515 | 0.170 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2021 | 137 | 0.160 |
Why?
|
| Disease Management | 1 | 2020 | 248 | 0.160 |
Why?
|
| Coronary Disease | 1 | 2020 | 358 | 0.160 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 172 | 0.160 |
Why?
|
| Software | 1 | 2020 | 418 | 0.150 |
Why?
|
| Recurrence | 1 | 2020 | 948 | 0.150 |
Why?
|
| Young Adult | 4 | 2021 | 5710 | 0.150 |
Why?
|
| Calcium | 2 | 2018 | 929 | 0.140 |
Why?
|
| Angina, Stable | 1 | 2016 | 13 | 0.140 |
Why?
|
| Cohort Studies | 2 | 2020 | 2356 | 0.140 |
Why?
|
| Coronary Restenosis | 1 | 2016 | 42 | 0.140 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 286 | 0.140 |
Why?
|
| Treatment Outcome | 4 | 2022 | 7028 | 0.140 |
Why?
|
| Stents | 2 | 2021 | 657 | 0.130 |
Why?
|
| Adult | 8 | 2021 | 21379 | 0.130 |
Why?
|
| Adolescent | 4 | 2021 | 8904 | 0.130 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2022 | 756 | 0.130 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 3256 | 0.120 |
Why?
|
| Heart Aneurysm | 1 | 2014 | 21 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 201 | 0.120 |
Why?
|
| Exercise Test | 1 | 2014 | 242 | 0.110 |
Why?
|
| Area Under Curve | 3 | 2016 | 238 | 0.100 |
Why?
|
| Risk Factors | 5 | 2022 | 5720 | 0.100 |
Why?
|
| Constriction, Pathologic | 2 | 2022 | 236 | 0.100 |
Why?
|
| Adipose Tissue | 2 | 2022 | 221 | 0.090 |
Why?
|
| Prospective Studies | 4 | 2022 | 3703 | 0.090 |
Why?
|
| Obesity | 1 | 2016 | 1074 | 0.080 |
Why?
|
| Hydrodynamics | 2 | 2019 | 15 | 0.080 |
Why?
|
| Purines | 2 | 2021 | 39 | 0.080 |
Why?
|
| Body Mass Index | 3 | 2016 | 866 | 0.080 |
Why?
|
| Pyrazoles | 2 | 2021 | 190 | 0.070 |
Why?
|
| Electrocardiography | 2 | 2022 | 601 | 0.070 |
Why?
|
| Germany | 2 | 2016 | 67 | 0.070 |
Why?
|
| Triiodobenzoic Acids | 2 | 2016 | 28 | 0.070 |
Why?
|
| Survival Rate | 2 | 2019 | 1055 | 0.070 |
Why?
|
| Patient Care Planning | 2 | 2016 | 108 | 0.060 |
Why?
|
| Cardiac-Gated Imaging Techniques | 2 | 2014 | 60 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 2 | 2018 | 503 | 0.060 |
Why?
|
| South Carolina | 2 | 2019 | 2752 | 0.050 |
Why?
|
| Heart Atria | 1 | 2021 | 206 | 0.050 |
Why?
|
| Ischemia | 1 | 2022 | 229 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 2222 | 0.040 |
Why?
|
| Acute Pain | 1 | 2020 | 35 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2019 | 83 | 0.040 |
Why?
|
| Asia | 1 | 2019 | 59 | 0.040 |
Why?
|
| North America | 1 | 2019 | 111 | 0.040 |
Why?
|
| Tomography, Spiral Computed | 1 | 2019 | 57 | 0.040 |
Why?
|
| China | 1 | 2019 | 138 | 0.040 |
Why?
|
| Europe | 1 | 2019 | 196 | 0.040 |
Why?
|
| Equipment Design | 1 | 2020 | 500 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2019 | 133 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 159 | 0.040 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 81 | 0.040 |
Why?
|
| Injections, Intra-Arterial | 1 | 2017 | 30 | 0.040 |
Why?
|
| Pre-Eclampsia | 1 | 2019 | 202 | 0.040 |
Why?
|
| Filtration | 1 | 2017 | 61 | 0.040 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2016 | 52 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 730 | 0.030 |
Why?
|
| United States | 2 | 2019 | 7338 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1265 | 0.030 |
Why?
|
| Reference Standards | 1 | 2015 | 115 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 138 | 0.030 |
Why?
|
| Syncope | 1 | 2014 | 23 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 1425 | 0.030 |
Why?
|
| Review Literature as Topic | 1 | 2014 | 24 | 0.030 |
Why?
|
| Acute Chest Syndrome | 1 | 2014 | 19 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1609 | 0.030 |
Why?
|
| Sesquiterpenes | 1 | 2014 | 41 | 0.030 |
Why?
|
| Vascular Patency | 1 | 2014 | 122 | 0.030 |
Why?
|
| Iopamidol | 1 | 2014 | 37 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 119 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 880 | 0.030 |
Why?
|
| Adenosine | 1 | 2014 | 165 | 0.030 |
Why?
|
| Forecasting | 1 | 2015 | 277 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2015 | 453 | 0.030 |
Why?
|
| Pregnancy | 1 | 2019 | 2334 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1046 | 0.030 |
Why?
|
| Heart Rate | 1 | 2015 | 568 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2014 | 239 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 1419 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2014 | 738 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 4655 | 0.020 |
Why?
|
| Child | 1 | 2014 | 6401 | 0.010 |
Why?
|